HCL Tech Q4 preview: HCL Technologies' share price rallied 3% in intraday deals on Monday, April 21, ahead of the announcement of the March 2025 quarter earnings, slated to be released on Tuesday ...

HCL Tech Q4 result: HCL Tech reported an 8 per cent YoY increase in consolidated net profit to ₹4,307 crore. Photo: Pradeep Gaur/Mint(Mint) "HCL Tech grew the fastest among our peers for the ...

HCL Tech expects its revenue growth in the financial year 2026 to range between 2 per cent and 5 per cent. (Photo: Reuters) HCL Technologies is all set to announce its Q4FY25 results on today ...

HCL Tech expects its revenue growth in the financial year 2026 to range between 2 per cent and 5 per cent. (Photo: Reuters) HCL Technologies saw ‘strong new bookings of $3 billion’ during the ...

HCL Technologies experienced a decline in today's trading session, with its shares falling by 1.06% to a price of Rs 1,562.50. The trading volume was notably high, indicating significant market ...

Plavix (clopidogrel) can cause side effects that range from mild to serious. More common side effects include bruising, bleeding, and itching. If side effects from Plavix become difficult to ...

HCL Technologies shares surged 7.68 per cent to ₹1,593.60 at 11.35 on the NSE on Wednesday, following its Q4 results announcement and optimistic FY26 guidance that outpaced industry peers.

Shares of HCL Technologies jumped over 7 percent to Rs 1,587 on April 23 after the IT giant posted January–March quarter (Q4FY25) results that were largely in line with expectations. While most ...

Analysts will also monitor performance in ER&D — a vertical where HCL has strong positioning — and whether discretionary spends are picking up. The results will be followed by a 7:30 p.m. conference ...

The body naturally produces a digestive acid called hydrochloric acid (HCL). This acid plays a vital role in breaking down food and absorbing nutrients. However, as we grow older, HCL production ...

Although a diminished pharmacodynamic effect of clopidogrel has been demonstrated in patients treated with proton-pump inhibitors (PPIs), whether its clinical efficacy is reduced remains highly ...

The US FDA has also recently issued a warning stating, "new data show that when clopidogrel and omeprazole are taken together, the effectiveness of clopidogrel is reduced. Patients at risk for ...